MedPath

DEEPALI KUMAR

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung Transplantation

Phase 4
Conditions
Varicella Zoster Vaccine
First Posted Date
2018-04-10
Last Posted Date
2020-10-19
Lead Sponsor
Deepali Kumar
Target Recruit Count
50
Registration Number
NCT03493776
Locations
🇨🇦

University Health Network, Toronto General Hospital, Multi-Organ Transplant, Toronto, Ontario, Canada

Clinical Evaluation of Quantiferon-Monitor to Predict Outcomes in Solid Organ Transplant Recipients

Completed
Conditions
Immunity, Cellular
First Posted Date
2015-09-25
Last Posted Date
2018-06-20
Lead Sponsor
Deepali Kumar
Target Recruit Count
151
Registration Number
NCT02560857
Locations
🇨🇦

University Health Network, Toronto General Hospital, Multi-Organ Transplant, Toronto, Ontario, Canada

News

No news found
© Copyright 2025. All Rights Reserved by MedPath